Intranasal peptide delivery: what it is and which peptides use it
Not every peptide is an injection. A handful of peptides use the nose because of where the nose connects.
TL;DR
- Intranasal delivery uses a nasal spray to absorb a peptide across the nasal lining.
- For some peptides this is a path directly to brain regions, not just the bloodstream.
- Bioavailability is usually lower than injection, but the trade-off can be worth it.
What it is
Intranasal peptide delivery is a route of administration (in plain English: a way of getting a medicine into the body) that uses a nasal spray instead of an injection. The peptide crosses the thin tissue inside the nose and enters the bloodstream — and, for small enough peptides, certain brain pathways too. The technical term for that brain shortcut is the nose-to-brain pathway.
How it works
Think of the nasal cavity as a small, vascular sponge sitting right under the base of the brain. When you spray a peptide into the nose, some of it crosses the sponge into the bloodstream. A smaller fraction can travel along the olfactory and trigeminal nerve sheaths — narrow paths that bypass the blood-brain barrier (in plain English: the security gate that normally keeps large molecules out of the brain). That second path is why intranasal oxytocin has been studied for stress and social cognition specifically (Quintana et al., Translational Psychiatry, 2017).
Who asks about it
People come to this topic when they have read that a peptide they are interested in is "available as a nasal spray" and want to know whether that is comparable to an injection. The underlying question is usually: is this easier and still effective, or is it a workaround?
What the research says
Bioavailability — the fraction of the dose that actually reaches the bloodstream — is usually lower for intranasal than for subcutaneous injection. Published intranasal oxytocin studies use higher doses to achieve effects similar to lower injected doses (Born et al., Nature Neuroscience, 2002). PT-141 (bremelanotide) is the most prominent intranasal peptide in clinical history, though the FDA-approved version (Vyleesi) is now an injection.
What to know before considering it
Intranasal sprays still require a valid prescription for any peptide currently regulated as a medication. Storage and sterility matter — a spray bottle stored at room temperature past its date is a real-world quality issue. Side effects can include nasal irritation, headache, and runny nose. Any peptide use requires evaluation by a licensed clinician.
The Halftime POV
Intranasal is not a magic shortcut and it is not a downgrade. It is a different route with different trade-offs. Whether it fits a protocol depends on the peptide, the dose, and the goal. That is the conversation a clinician should be having with you, not a marketing page.
Related reading:
FAQ
Q: What is intranasal peptide delivery? A: A method of giving a peptide as a nasal spray. The peptide is absorbed across the nasal lining and reaches the bloodstream and, for some peptides, parts of the brain.
Q: Which peptides come as a nasal spray? A: Examples in published research include oxytocin, PT-141 (bremelanotide), selank, and semax. Each has different bioavailability and clinical context.
Q: Is intranasal as effective as injection? A: Not always. Intranasal bioavailability is usually lower than subcutaneous injection. The trade-off is no needle, faster start of action for some peptides, and direct access to brain pathways.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.
Sources
- Quintana et al., Translational Psychiatry, 2017 — intranasal oxytocin pharmacokinetics
- Born et al., Nature Neuroscience, 2002 — sniffing neuropeptides bypass the blood-brain barrier
This article discusses compounds that are currently under FDA Category 2 review (see our FDA categorization explainer). These compounds are not currently part of Halftime Health's published protocol catalog. This article is provided for educational purposes only and does not constitute medical advice or an offer to sell.
Frequently asked questions
What is intranasal peptide delivery?
A method of giving a peptide as a nasal spray. The peptide is absorbed across the nasal lining and reaches the bloodstream and, for some peptides, parts of the brain.
Which peptides come as a nasal spray?
Examples in published research include oxytocin, PT-141 (bremelanotide), selank, and semax. Each has different bioavailability and clinical context.
Is intranasal as effective as injection?
Not always. Intranasal bioavailability is usually lower than subcutaneous injection. The trade-off is no needle, faster start of action for some peptides, and direct access to brain pathways.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.